Autonomic neuropathy in Fabry disease: A prospective study using the Autonomic Symptom Profile and cardiovascular autonomic function tests

BMC Neurology

Volumn 10, Issue , 2010, Pages

  Biegstraaten, Marieke ^a   van Schaik, Ivo N ^a   Wieling, Wouter ^b   Wijburg, Frits A ^c   Hollak, Carla E M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Medical Center   (Netherlands)

^c EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME;

ADOLESCENT; ADULT; AGED; ANALYTIC METHOD; ARTICLE; AUTONOMIC DYSFUNCTION; AUTONOMIC NEUROPATHY; AUTONOMIC SYMPTOM PROFILE; CARDIOVASCULAR AUTONOMIC FUNCTION TEST; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME REPLACEMENT; FABRY DISEASE; FEMALE; HUMAN; MALE; ORTHOSTATIC INTOLERANCE; SCHOOL CHILD; SEXUAL DYSFUNCTION; SYMPTOM; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; HOSPITALIZATION; MIDDLE AGED; PROSPECTIVE STUDY; QUESTIONNAIRE; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; AUTONOMIC NERVOUS SYSTEM DISEASES; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHILD; ENZYME REPLACEMENT THERAPY; FABRY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; YOUNG ADULT;

EID: 77954293131     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-10-38     Document Type: Article

References (30)

1. Luciano CA, Russell JW, Banerjee TK, Quirk JM, Scott LJ, Dambrosia JM, et al. Physiological characterization of neuropathy in Fabry's disease. Muscle Nerve 2002, 26:622-629. 10.1002/mus.10236, 12402283.
2. Scott LJC, Griffin JW, Luciano C, Barton NW, Banerjee T, Crawford T, et al. Quantitative analysis of epidermal innervation in Fabry disease. Neurology 1999, 52:1249-1254.
3. Rahman AN, Lindenberg R. The neuropathology of hereditary dystopic lipidosis. Arch Neurol 1963, 9:373-385.
4. Hilz MJ. Evaluation of peripheral and autonomic nerve function in Fabry disease. Acta Paediatr Suppl 2002, 439:38-42.
5. Kolodny EH, Pastores GM. Anderson-Fabry disease: extrarenal, neurological manifestations. J Am Soc Nephrol 2002, 13:S150-S153.
6. Cable WJ, Kolodny EH, Adams RD. Fabry disease: impaired autonomic function. Neurology 1982, 32:498-502.
7. Schiffmann R, Floeter MK, Dambrosia JM, Gupta S, Moore DF, Sharabi Y, et al. Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease. Muscle Nerve 2003, 28:703-710. 10.1002/mus.10497, 14639584.
8. Freeman R. Autonomic peripheral neuropathy. Neurol Clin 2007, 25:277-301. 10.1016/j.ncl.2007.01.001, 17324728.
9. Ramaswami U, Whybra C, Parini R, Pintos-Morell G, Mehta A, Sunder-Plassmann G, et al. Clinical manifestations of Fabry disease in children: Data from the Fabry Outcome Survey. Acta Paediatr 2006, 95:86-92. 10.1080/08035250500275022, 16498740.
10. Kampmann C, Wiethoff CM, Whybra CM, Baehner FA, Mengel E, Beck M. Cardiac manifestations of Anderson-Fabry disease in children and adolescents. Acta Paediatr 2008, 97:463-469. 10.1111/j.1651-2227.2008.00700.x, 18363956.
11. Ries M, Clarke JTR, Whybra C, Timmons M, Robinson C, Schlaggar BL, et al. Enzyme-replacement therapy with agalsidase alfa in children with Fabry disease. Pediatrics 2006, 118:924-932. 10.1542/peds.2005-2895, 16950982.
12. Morgan SH, Rudge P, Smith SJM, Bronstein AM, Kendall BE, Holly E, et al. The neurological complications of Anderson-Fabry disease (alpha-galactosidase A deficiency)--investigation of symptomatic and presymptomatic patients. Q J Med 1990, 75:491-507.
13. Whybra C, Kampmann C, Krummenauer F, Ries M, Mengel E, Miebach E, et al. The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy. Clin Genet 2004, 65:299-307. 10.1111/j.1399-0004.2004.00219.x, 15025723.
14. Beck M. The Mainz Severity Score Index (MSSI): development and validation of a system for scoring the signs and symptoms of Fabry disease. Acta Paediatr Suppl 2006, 95:43-46. 10.1080/08035320600618825, 16720464.
15. Gracely RH. Studies of pain in normal man. Textbook of pain 1994, 315-336. Wall PD, Melzack R.
16. Suarez GA, Opfer-Gehrking TL, Offord KP, Atkinson EJ, O'Brien PC, Low PA. The Autonomic Symptom Profile: a new instrument to assess autonomic symptoms. Neurology 1999, 52:523-528.
17. Kahn R. Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Autonomic nervous system testing. Diabetes Care 1992, 15:1095-1103.
18. Wieling W, van Brederode JF, de Rijk LG, Borst C, Dunning AJ. Reflex control of heart rate in normal subjects in relation to age: a data base for cardiac vagal neuropathy. Diabetologia 1982, 22:163-166. 10.1007/BF00283745, 7075917.
19. Moller AT, Feldt-Rasmussen U, Rasmussen AK, Sommer C, Hasholt L, Bach FW, et al. Small-fibre neuropathy in female Fabry patients: reduced allodynia and skin blood flow after topical capsaicin. J Peripher Nerv Syst 2006, 11:119-125. 10.1111/j.1085-9489.2006.00076.x, 16787509.
20. Hilz MJ, Kolodny EH, Brys M, Stemper B, Haendl T, Marthol H. Reduced cerebral blood flow velocity and impaired cerebral autoregulation in patients with Fabry disease. J Neurol 2004, 251:564-570. 10.1007/s00415-004-0364-9, 15164189.
21. Altarescu G, Moore DF, Pursley R, Campia U, Goldstein S, Bryant M, et al. Enhanced endothelium-dependent vasodilation in Fabry disease. Stroke 2001, 32:1559-1562.
22. Moore DF, Altarescu G, Herscovitch P, Schiffmann R. Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease. BMC Neurol 2002, 2:4. 10.1186/1471-2377-2-4, 116601, 12079501.
23. Moore DF, Altarescu G, Ling GSF, Jeffries N, Frei KP, Weibel T, et al. Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement. Stroke 2002, 33:525-531. 10.1161/hs0202.102601, 11823664.
24. Bouhassira D, Attal N, Willer JC, Brasseur L. Painful and painless peripheral sensory neuropathies due to HIV infection: a comparison using quantitative sensory evaluation. Pain 1999, 80:265-272. 10.1016/S0304-3959(98)00227-9, 10204739.
25. Heldestad V, Nordh E. Quantified sensory abnormalities in early genetically verified transthyretin amyloid polyneuropathy. Muscle Nerve 2007, 35:189-195. 10.1002/mus.20689, 17094098.
26. Shun CT, Wu HP, Hsieh SC, Lin WM, Lin YH, Tai TY, et al. Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain 2004, 127:1593-1605. 10.1093/brain/awh180, 15128619.
27. van Brakel WH, Nicholls PG, Wilder-Smith EP, Das L, Barkataki P, Lockwood DN, et al. Early diagnosis of neuropathy in leprosy-comparing diagnostic tests in a large prospective study (the INFIR Cohort Study). PLoS Negl Trop Dis 2008, 2:212.
28. McDougall AJ, McLeod JG. Autonomic neuropathy, I. Clinical features, investigation, pathophysiology, and treatment. J Neurol Sci 1996, 137:79-88. 10.1016/0022-510X(95)00355-6, 8782159.
29. Donaghy M, Hakin RN, Bamford JM, Garner A, Kirkby GR, Noble BA, et al. Hereditary sensory neuropathy with neurotrophic keratitis. Description of an autosomal recessive disorder with a selective reduction of small myelinated nerve fibres and a discussion of the classification of the hereditary sensory neuropathies. Brain 1987, 110:563-583. 10.1093/brain/110.3.563, 3472625.
30. Hoffmann B, Schwarz M, Mehta A, Keshav S, . Fabry Outcome Survey European Investigators Gastrointestinal symptoms in 342 patients with Fabry disease: prevalence and response to enzyme replacement therapy. Clin Gastroenterol Hepatol 2007, 5:1447-1453. 10.1016/j.cgh.2007.08.012, 17919989, Fabry Outcome Survey European Investigators.